Innovation Week Events

launch

Welcome to Innovation Week 2016! Join us for exciting public talks, debates and conversations to discuss, celebrate and promote STEMM innovation in Australia. Contact us to register your event and learn more – all welcome!

@@@

Tuesday 1 November 2016

CANBERRA

Lean Startup Workshop – Business Model Generation

Canberra Innovation Network

When: 1:00pm – 4:30pm

Where: Canberra Innovation Network, Level 5, 1 Moore St, Canberra, ACT VIEW MAP

BOOK HERE

@@@

Monday 7 November 2016

MELBOURNE

Innovation Week 2016 – Official Launch

Genomics and Personalised Medicine: Have we arrived at our destination?

BioMelbourne Network

Join us for a delicious breakfast buffet and two cutting-edge talks about genomics and personalised medicine – the future is now. This event will be hosted by BioMelbourne Network at the historical Royal Society of Victoria.

Chair

krystal-evans-march-2016-hi-resDr Krystal Evans, CEO BioMelbourne Network

Krystal was appointed CEO of the BioMelbourne Network in July 2014 and has over 15 years experience in the biomedical research sector. Krystal’s skills in government affairs, stakeholder relations and business development underpin her commitment to advancing Melbourne’s unique position as a global destination for life sciences and health technology. Krystal is a leading advocate for science and technology, and was a founding member and Chair of the Australian Academy of Science Early- and Mid-Career Researcher Forum. A champion of the 2011 “Discoveries Need Dollars” campaign, she led the Melbourne “Rally for Research” to protect funding for medical research in Australia. Committed to science communication and outreach, Krystal is a regular presenter on Melbourne community radio station 3RRRFM’s science show “Einstein A-Go-Go”. Krystal has an undergraduate degree in medicinal chemistry and holds a PhD in medical biology undertaken at the Walter and Eliza Hall Institute.

Opening

minister-huntVideo Opening: Hon. Greg Hunt MP, Minister for Industry, Innovation and Science, Australian Government

Greg was elected as the Federal Member for Flinders in 2001, and became Parliamentary Secretary to the Minister for the Environment and Heritage and then Parliamentary Secretary to the Minister for Foreign Affairs as a young MP in the Howard Government. Greg was Shadow Minister in the Environment portfolio between 2007 and 2013, and was Minister for the Environment between September 2013 and July 2016. In 2016 he was selected as the inaugural Best Minister in the World recipient at the World Government Summit. In July 2016 Greg was appointed Minister for Industry, Innovation and Science.

margaret-hartley

Dr Margaret Hartley, Chief Executive Officer, Australian Academy of Technological Sciences and Engineering

Dr Hartley holds a BAppSci (RMIT) and PhD (Monash University). She joined the Academy as CEO in 2009 and leads the implementation of policy and strategy for the Academy. Dr Hartley was previously the Principal Scientific Advisor to the Australian Government Department of Health and Ageing and the Director of the Office of Chemical Safety. She led the Department’s human health risk assessment of pesticides and chemicals as well as regulatory policy and environmental health policy. She oversaw regulatory compliance activities for narcotics, controlled substances, and drugs in sports and advised the Commonwealth on chemical security issues. Dr Hartley is a respected national and international leader and regulatory scientist with wide experience in leading and managing Australia’s chemical regulatory policy framework, and developing and implementing related human health policy. Dr Hartley previously held research and academic positions in Pharmacology and then Public Health and Epidemiology at Monash University and the Australian National University.

Speakers

Annual Report 2013Professor Kathryn North, Director, Murdoch Childrens Research Institute

Professor North has received a number of awards for her research including the GSK Australia Award for Research Excellence in 2011, the Ramaciotti Medal for Excellence in Biomedical Research in 2012 and the Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research in 2012. Professor North is Chair of the NHMRC Research Committee and a Member of the NHMRC Council. In 2013, Professor North was appointed Vice Chair of the Steering Committee and Co-Chair of the Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH). GA4GH is an international consortium of more than 200 institutions across 30 countries, focusing on the global sharing of genomic and clinical data and its application to improvement in patient diagnosis and treatment.

ajeet-e1475128883820Associate Professor Ajeet Singh MD, CEO and Founder, CNSDose

Dr Ajeet Singh is an award-winning Australian Psychiatrist and Pharmacogeneticist with an international standing in the field. He is the CEO of CNSDose, a Melbourne based start-up which is a cloud-based medication guidance system enabling doctors and patients to reduce trial and error in prescribing anti-depressants.

When: 7:15am – 9:00am

Where: Royal Society of Victoria, 8 La Trobe St, Melbourne VIEW MAP

BOOK HERE

@@@

Monday 7 November 2016

MELBOURNE

CI 2016 Asia Pacific: The Exponential Shift. Making transformation happen

Creative Innovation – a Creative Universe event

When: 7-9 November, 2016 (various times)

Where: Sofitel Melbourne on Collins, Melbourne VIEW MAP

BOOK HERE

@@@

Monday 7 November 2016

MELBOURNE

Hugh Rogers Fellowships Announcements

Melbourne Town Hall, Melbourne

When: Invitation only

Where: Melbourne Town Hall, Swanston St/Collins St, Melbourne

@@@

Monday 7 November 2016

SYDNEY

Creating communities to drive biomedical commercialisation: connecting talent in industry and academia

Michael Crouch Innovation Centre UNSW

An expert panel discussion on fostering academia-industry networks, the importance of diversity in skills, culture and gender diversity, and partnering with pharmaceutical companies. A catered networking session will follow.

Facilitators

mel-thomsonDr Melanie Thompson, General Manager of Education, Skills and Events, MTP Connect

Mel completed her Honours degree in microbiology and immunology at the University of Melbourne in 1998. She then migrated to the UK where she worked on various projects as diverse as allergy and cancer before undertaking further studies. She completed a Masters of Research then a PhD in microbial genetic regulation in Neisseria species, both at University of York, UK. After the award of her PhD in 2009, she became interested the host-pathogen interactions at the Leeds Institute of Molecular Medicine, UK. Dr Thomson returned to Australia in 2011 to start her own research group at Deakin Medical School and the Geelong Centre for Emerging Infectious Diseases. A passionate science communicator, she has recently become a national ‘torch bearer’ for the concept of crowd funding academic research, which a track record of three successful ‘Pozible’ crowd funding campaigns, ‘Mighty Maggots’, ‘Hips 4 Hipsters’ and ‘No more Poo Taboo’. Mel is very active on Twitter with over 9000 followers and advocates for women in science both nationally and internationally.

alfredo-martinez-collDr Alfredo Martinez-Coll, General Manager, Stakeholder Engagement, MTP Connect and Senior Business Development Manager at UNSW Innovations

Alfredo is a Graduate of the Australian Institute of Company Directors, a Registered Technology Transfer Professional and a member of the NSW AusMedTech (Medical Devices) Committee of AusBiotech. With a BSc in Biomedical Engineering from Louisiana Tech University (USA), a PhD and postdoctoral training in biomedical sciences from University of Technology Sydney, Alfredo brings more than 16 years’ research experience in the areas of: artificial organs, cardiovascular and cerebrovascular physiology, membrane transport, and oxygen transport to tissue. He has been working as business development manager in Technology Transfer and Commercialisation for the past 13 years at public hospitals and in academia. Alfredo’s main areas of interest are sustainable funding for science, entrepreneurship and innovation, project management in science and business development. He is passionate about engaging with researchers and Industry specialist in the Life Sciences arena to translate research discoveries into social impact. He currently holds the position of Senior Business Development Manager at UNSW Innovations.

Expert Panellists:

k-connellKathy Connell – Director, New Ventures ANZ, Johnson & Johnson California Innovation Centre

Kathy is Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation, Asia-Pacific and is responsible for implementing our strategy across Australia and New Zealand. Kathy has a clinical background and started her commercial career as the VP of Global Business Development for an Australian biotechnology company. Prior to joining Janssen, Kathy worked for Sanofi engaged in in-licensing late stage pharmaceutical assets. Kathy joined Janssen as Biotechnology Alliance Manager in 2011. Kathy is a registered psychologist and holds Post Graduate Diplomas in Health and Medical Law from the University of Melbourne, Psychology from Monash University and Bachelor degrees in Psychology (Swinburne University) and Applied Science from LaTrobe University. She is based in Sydney Australia.

d-kellyProfessor Darren Kelly – ‎CEO and Managing Director, OccuRx; Entrepreneur in Residence, ‎Brandon Capital Partners; Associate Dean, Innovation and Commercialisation, Director of Biomedical Research, University of Melbourne, St Vincent’s Hospital Melbourne

Darren has more than 25 years of management and research experience in the life sciences sector, particularly relating to drug development. He is Associate Dean (Innovation and Commercialisation), Professor and Director of Biomedical Research in the Department of Medicine at The University of Melbourne, St Vincent’s Hospital Melbourne, and an Entrepreneur in Residence with Brandon Capital. He was a Founder, CEO and Director of Fibrotech Therapeutics, a company developing orally active anti-fibrotic inhibitors to treat underlying pathological fibrosis in kidney and heart failure. Fibrotech was sold to Shire Plc for a record $75m USD upfront including milestone payments up to $560m USD. He has published widely in pre-clinical novel interventions and in developing experimental models of cardiovascular disease. Darren was awarded the prestigious TJ Neale Award in 2009 for outstanding contributions to nephrology. He was also awarded best R&D company and best bioctehnology company deal 2014. Darren is a member of the Australian Institute of Company Directors, Ausbiotech, BioMelbourne network and a Fellow of the American Society of Nephrology.

m-millerDr Michelle Miller, Managing Director, Biotron

Michelle has spent over 20 years in the bioscience industry, with extensive experience in commercial development of early to mid stage technologies. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of oncogene-mediated cancer development. Her experience includes several years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. In 1999 she moved into the finance industry as an Investment Manager with a specialist bioscience venture capital fund, and undertook studies at the Securities Institute of Australia. She has been CEO and Managing Director of Biotron since early 2002.

dazDr Darren Saunders, Cancer Researcher and Senior Lecturer, UNSW and visiting fellow, Kinghorn Cancer Centre, The Garvan Institute

Darren is a cancer biologist at UNSW and visiting fellow at the Kinghorn Cancer Centre, Garvan Institute. He was a founding member and deputy chair of the Australian Academy of Science Early-Mid Career Researcher Forum, awarded an Australian Leadership Award and a NSW Life Scientist Research Award, and has held fellowships from the US Dept of Defense and Cancer Institute NSW. Darren’s research focuses on two key cellular stress adaptation mechanisms in cancer and neurodegeneration: maintenance of proteostasis via the Ubiquitin Proteasome System, and metabolic reprogramming. His work integrates various platforms to better understand genotype-phenotype relationships including proteomics, genomics, and metabolomics and developing creative technology-based approaches to visualizing and communicating complex data. Darren is an active science communicator, makes regular radio and TV appearances, and contributions to print and online media internationally.

sheila

Dr Sheila Donnelly, Senior Lecturer, Helmedix | University of Technology Sydney

A Senior lecturer within the University of Technology, Sydney (UTS) Faculty of Science, Sheila is course coordinator of Biotechnology and a member of the ithree Institute. Her research led to the discovery of a protein secreted by helminth parasites that modulates cells of the innate immune system, specifically, activating macrophages towards an alternative phenotype which has downstream effects on the host T cell response. At UTS Sheila’s research aims to understand the mechanisms by which helminth parasites successfully manipulate their host’s immune system; and to develop novel therapeutics for the treatment of autoimmune disease. Sheila has published widely and more recently been involved in commercialisation of her research findings in the areas of human health.

martijn-bDr Martijn Bijker, Founder, From Science to Pharma

Martijn Bijker is founder of the company “from SCIENCE to PHARMA” – the first online Medical Science Liaison (MSL) training company for professionals who want to move into a MSL role, but do not have any MSL experience.

When: 5:00pm – 7:30pm

Where: Michael Crouch Innovation Centre, ground floor, Building E10, UNSW, Sydney VIEW MAP

BOOK HERE

@@@

Tuesday 8 November 2016

MELBOURNE

CI 2016 Asia Pacific: The Exponential Shift. Making transformation happen

Creative Innovation – a Creative Universe event

When: 7-9 November, 2016 (various times)

Where: Sofitel Melbourne on Collins, Melbourne VIEW MAP

BOOK HERE

@@@

Wednesday 9 November 2016

MELBOURNE

Innovation from the university sector – to spin out or license?

Monash College, Melbourne

Commercialisation of university-based discoveries in medical research is increasing in Australia and contention exists over whether forming a start-up company, or licensing to a more resourceful company, provides better outcomes for the inventor, the university and Australia’s economy. Our panel, with experience in venture capital, angel investing, start-up companies, industry and universities, will debate the merits and pitfalls encountered with each approach, and challenge mainstream thinking.

Facilitator

michelle-gallaher_the-social-scienceMichelle Gallaher, Co-Founder and Creative Director, The Social Science and Co-Founder, Women in STEMM Australia

Michelle is Co-Founder and Creative Director at The Social Science. Her expertise encompasses healthcare and biotechnology having worked in biotech start-ups, major teaching hospitals, research organisations and pharmaceutical companies throughout her 20+ year career. As former CEO of the BioMelbourne Network, Michelle developed an international professional network. Passionate about small business and entrepreneurship, Michelle is an influential advocate for women in science, technology, engineering, mathematics and medicine (STEMM). Michelle is also a TEDx Melbourne alumni, an avid blogger and tweeter, and regularly speaks on innovation in Australia and women in leadership. She is Co-Founder of Women in STEMM Australia and is keen to encourage more women in STEMM to become entrepreneurs and innovators.

Expert Panellists

elaine-steadDr Elaine Stead, Managing Director of Venture Capital, Blue Sky

Elaine has worked for a number of years as a venture capitalist and management consultant to the venture and industry across Australia and the US. She is currently responsible for the management of the Blue Sky venture capital fund and portfolio. As an Investment Manager at CM Capital Investments, Elaine focused on investment origination, portfolio management as well as portfolio company performance. Elaine has also worked in strategic management consulting, with both NASDAQ and ASX listed and private companies based in Australia and the US. Originally trained as a stem cell biologist, Elaine has since spent the last decade within the innovation and investment spectrum, initially in technology commercialisation assisting public institutions and founders translate and commercialise their technology across a broad range of industry sectors including agriculture, healthcare and IT. Elaine has a strong academic foundation holding a PhD in biochemistry from the University of Adelaide.

chris-nave

Dr Chris Nave, Founding Partner, Brandon Capital Partners and Principal Executive, Medical Reserach Commercialisation Fund

Chris is a founding partner of Brandon Capital Partners and Principal Executive of the Medical Research Commercialisation Fund. Chris was previously Director of Commercialisation at the Baker IDI Heart and Diabetes Institute, Manager of the biotechnology team at Melbourne Ventures and an Investment Manager for Uniseed. Chris has international experience with Leiras Pharmaceuticals in Finland, a wholly owned subsidiary of Schering AG, working for their Business Development group. He successfully moved companies to the US, securing investment from US investors for these companies. Chris was Chairperson of Fibrotech Therapeutics at the time of its successful sale to Shire and a Director of Spinifex Pharmaceuticals at the time of its sale to Novartis. He is currently a Director of OccuRx, Osprey Medical, PolyActiva, Global Kinetics Corporation and Cardiora. Chris has a PhD in Endocrinology and Physiology from the University of Melbourne and he has completed the Private Equity and Venture Capital Program at Harvard Business School.

anna_lavelleDr Anna Lavelle, inaugural CEO and Executive Director, AusBiotech

Anna was appointed the first CEO and Executive Director of AusBiotech in 2005. She also chairs and/or is a member of various Federal and State Government committees associated with biotechnology, including the Victorian Biotechnology Advisory Council, the Pharmaceuticals Industry Strategy Group, the R&D Tax Incentive Advisory Committee (all state and federal Ministerial appointments) and the Pharmaceuticals Industry Council. Anna was previously a Senior Executive with the Australian Red Cross Blood Service, commencing in 1998 as Director responsible for Strategic Planning and Business Development. She has held positions of Chief Executive Officer of a public health organisation, Industry Lobbyist for a member organisation and commenced employment as an academic at Monash University, Melbourne. Anna holds a PhD in Genetics from the University of Melbourne.

julian-clarkDr Julian Clark, Head of Business Development, Walter and Eliza Hall Institute

As Head of Business Development at the Walter and Eliza Hall Institute in Melbourne, Julian is responsible for IP management, technology transfer, commercial collaborations, and opportunity development. Julian has more than 30 years of international and cross-cultural business experience in growing and leading technology, research and healthcare enterprises, large and small. Julian also operates his own consulting business, Julian Clark Consulting Pty Ltd., and has had senior executive positions in Sweden, Great Britain, Japan, North America, India and Australia, including being CEO of Pharmacia LKB Biotech (Uppsala, Sweden), Chairman/Managing Director of Biochrom (Cambridge, UK), and Chief Operating Officer of Faulding Pharma (Adelaide, Australia). Recently, he was the founding CEO of the Cancer Therapeutics CRC, a Director of Alchemia and Genera Biosystems. Currently, Julian is a Director of Catalyst Therapeutics, Cancer Trials Australia and BioGrid Australia. Julian has a PhD from the University of Glasgow and an Honorary Doctorate from the University of South Australia.

elane_125pxDr Elane Zelcer, Case Manager, Accelerating Commercialisation and Executive Director, BioConsult

Elane is a Case Manager with Accelerating Commercialisation, a Federal Government initiative providing expert assistance to researchers, entrepreneurs and inventors wanting to commercialise their technologies. Elane is also Executive Director of BioConsult which focuses on assisting companies to develop their intellectual property through strategic partnering, capital raising and collaboration. Elane has considerable experience in the Biotechnology sector, including Chief Executive Officer positions with various biotech companies and Montech, the precursor to Monash Industry Engagement & Commercialisatoin. Elane is also the National Convenor for Hadassah Australia’s AUSiMED program. Elane holds a PhD in Physiology.

daniel-grantDr Daniel Grant, Pro Vice-Chancellor, Industry Engagement, La Trobe University

Dan is Pro Vice-Chancellor for Industry Engagement at La Trobe University. Previously, he was the Head of Pfizer’s External Research and Development Innovation group for Australia, New Zealand and Singapore. He was responsible for identifying, evaluating and managing collaborative and licensing opportunities that align with Pfizer’s Worldwide R&D strategies. Prior to joining Pfizer, Dan was a senior business development manager at Melbourne Ventures, a member of the Investment Committee for Uniseed and a Senior Business Development Manager for Biocomm Services. Dan has sat on the board of the CRC for Mental Health and a number of biotechnology spin-out companies, and is a past Director of Research Australia. Dan has a PhD in Cardiovascular Physiology and a Masters of Business Administration (MBA).

When: 6:00pm-7:30pm; drinks from 5:30pm

Where: Monash College, Level 7, 271 Collins St, Melbourne, Victoria VIEW MAP

BOOK HERE

@@@

Wednesday 9 November 2016

MELBOURNE

CI 2016 Asia Pacific: The Exponential Shift. Making transformation happen

Creative Innovation – a Creative Universe event

When: 7-9 November, 2016 (various times)

Where: Sofitel Melbourne on Collins, Melbourne VIEW MAP

BOOK HERE

@@@

Thursday 10 November 2016

MELBOURNE

BENCH TO BUSINESS

The Hatchtech story: from innovation to commercialisation

Murdoch Childrens Research Institute

vernSpeaker: Associate Professor Vern Bowles, Founder and Chief Scientific Officer, Hatchtech

Vern is the founder and Chief Scientific Officer of Hatchtech Pty Ltd, a specialty pharmaceutical company developing Xeglyze® Lotion, a proprietary next generation head lice treatment. Founded in 2001, Hatchtech was the culmination of 15 years of Vern’s research career studying the role of ectoparasite proteases in parasite infections, parasite nutrition and immune evasion in the sheep blowfly. In September 2015, Hatchtech announced the signing of a commercialisation agreement with integrated pharmaceutical company Dr. Reddy’s Laboratories (NYSE: RDY) for the rights of Xeglyze® Lotion in key territories.  If approved by the FDA, Xeglyze® will be available in the US in 2017. Vern is also an Associate Professor within the Faculty of Veterinary and Agricultural Sciences at the University of Melbourne, and completed a Bachelor of Agricultural Science from La Trobe University in 1983, and gained his PhD from the same institution in 1988.

When: 4:00pm  – 5:00pm

Where: Murdoch Childrens Research Institute, Danks Seminar Room L5, Royal Children’s Hospital VIEW MAP

RSVP HERE

@@@

Thursday 10 November 2016

MELBOURNE

STEMM Central Bootcamp: Design Thinking Masterclass

Biomedical Research Victoria

stemm-central-workshopA collaboration with Swinburne’s Design Factory this Masterclass will introduce you to the concepts of human-centered design and how to create innovative, effective and sustainable solutions for your research project or venture. STEMM = science, technology, engineering, mathematics and medicine.

For more information contact info@stemmcentral.com.

When: 9:00 am – 11:00 am

Where: Swinburne Hawthorn Campus, AMDC Building, 453 Burwood Rd, Hawthorn

BOOK HERE

@@@

Thursday 10 November 2016

MELBOURNE

“Content is King” and Other Myths Around Science Communication

Royal Society of Victoria

The so-called information age we live in could just as well be called the “misinformation age”. The public awareness of science and capacity for critical thinking seems more important than ever before – particularly for successful, effective innovation. One key to the public understanding of science and scientific thinking is scientists’ understanding of the media. Insights into what gets on screen, on air, online or in print, and why and how, is useful for crafting tomorrow’s messages for various media and audiences. There is a chorus of scientists saying they don’t have time for science communication or to ‘up’ their media skills. And why should they? Things get “dumbed-down”, the media gets it wrong, and some people don’t respond to logic. However, researchers can overcome all of these issues. But be warned – some approaches will be counter intuitive and involve dispelling some myths around science communication. An important thought: are we now in an era where content is the new King?

Speaker: Dr Andi Horvath, Media Advisor, Podcast Producer and Communications Trainer, The University of Melbourne

andi-horvath_a_116x116Dr Andi Horvath is currently a guest lecturer for Science in the Media, a Podcast producer and Pod Hub Coordinator for the University of Melbourne. Andi has a PhD in Medicine, an MBA and qualifications in Media and Science Communication. Andi won an international award for her podcast series Access All Areas made for Museum Victoria where she was a Senior Curator. Known as Dr Andi, she was a science producer and broadcaster on 3RRR for over 20 years and has also worked for ABC and SBSTV. Andi has produced exhibitions, videos, audio, public programs, training programs, blogs and articles for organizations including the University of Melbourne and CSIRO. A seasoned public speaker, Andi has lectured and tutored in Science Education, Science Communication and Science in Society.

When: 7:00 PM – 8:15 PM

Where: Royal Society of Victoria, 8 La Trobe St, Melbourne VIEW MAP

BOOK HERE

@@@

Thursday 10 November 2016

ORANGE

STEM Action School Engagement Event: STEM at Canobolas

Canobolas Rural Technology High School

Learn about the innovative Year 7 and 8 STEM curriculum at The Canobolas Rural Technology High School. The program aims to re-engage students (girls and boys) through STEM project-based learning, while developing 21st Century learning skills of communication, collaboration, creativity and critical thinking. This will assist in making these students the employees of choice in a competitive local future workforce.
Industry engagement through events like this will allow us to focus on the skills desired by local industry.

Who can attend: all parents, local industries and the wider school community are welcome.

When: 5.00pm – 6.00pm

Where: The Canobolas Rural Technology High School STEM Centre, Icely Rd, Orange (enter through the Adminstration building on Icely Rd) VIEW MAP

FREE REGISTRATION HERE

@@@

Thursday 10 November 2016

PERTH

The Science of Life and Death: LIFE in Perth

Australian Academy of Science

Life is a strange subject, but it affects us all—one Australian is born every 1.45 minutes, while one dies every 3.25 minutes. We’re good at talking about the beginnings of life, but pretty awkward when it comes to facing the end.

LIFE in Perth will explore the science behind life’s beginnings; the use of artificial wombs; extending life and improving health through genetic modification; and the ethical and regulatory challenges posed by the emergence and use of these new and innovative techniques and technologies. More information available here.

slide1

Host

bernie-hobbsBernie Hobbs, ABC Science Writer, Broadcaster and Host

For more than two decades Bernie Hobbs has been talking and writing about her great passion first in the classroom, then at the ABC and hosting science events around Australia. Bernie is best known as a popular judge from ABC TV’s The New Inventors, and she’s a firm favourite with audiences for her weekly science spots on ABC radio with Red Symons (ABC Melbourne), James Valentine (ABC Sydney) and Richard Fidler (ABC Brisbane). Bernie has a rare combination of sharp intellect, quick wit and warmth. With a background in medical research, environmental writing and science teaching, Bernie can tackle tough or technical subjects and bring the driest topics alive for lay or expert audiences.

Speakers

hayley-dickinsonDr Hayley Dickinson, Head,  Embryology and Placental Biology, The Ritchie Centre, Hudson Institute for Medical Research

Hayley is a reproductive physiologist and currently a NHMRC Career Development Fellow. Her research aims to save babies lives and reduce the burden of major perinatal conditions such as birth asphyxia and intrauterine growth restriction, through targeted antenatal interventions. Foetal growth and development underpin life-long health. She leads clinical studies that unravel the relationship between maternal diet and pregnancy outcomes. She is undertaking a large, prospective study at Monash Health, to determine the normal range of creatine in pregnancy and establish whether low creatine levels are associated with poor pregnancy outcomes.

mcgivernbDr Brenda McGivern, Law School, University of Western Australia

Brenda is a legal practitioner and academic who practises, researches and teaches in the areas of health, torts and insurance law.  She is the Deputy Dean of Law at the University of Western Australia, and continues to practise as a Consultant with Moray & Agnew Lawyers in Perth.  She is also the Chair of the Reproductive Technology Council of WA, and a member of the Clinical Ethics Service for Princess Margaret Hospital and King Edward Memorial Hospital.

ryan_listerv2Professor Ryan Lister, Lister Lab, Harry Perkins Institute of Medical Research, University of Western Australia (UWA)

Ryan leads a scientific research group exploring the epigenome. After receiving his PhD from UWA, Ryan undertook postdoctoral studies at The Salk Institute USA where he developed new techniques to map the epigenome, the molecular code superimposed upon the genome that plays crucial roles in regulating the information contained in the underlying DNA sequence. His discoveries include generating the first accurate maps of the human epigenome, and characterizing the suprising complexity of the human brain epigenome. His research has yielded new insights into the composition and function of the epigenome in a variety of systems, including plants, the brain, stem cells, and developing vertebrate embryos. Returning to UWA in 2012, Ryan’s laboratory is focused upon understanding how the epigenome patterns are established and changed, how they affect the readout of underlying genetic information, their involvement in plant growth and human disease, their role in brain development and function, and developing molecular tools to precisely edit the epigenome. Ryan’s awards include Young Tall Poppy of the Year for Western Australia (2013), the Frank Fenner Prize for Life Scientist of the Year (Prime Minister’s Prizes for Science, 2014), the Ruth Stephens Gani Medal for distinguished research in human genetics (Australian Academy of Science, 2014), and the Metcalf Prize for Stem Cell Research (National Stem Cell Foundation of Australia, 2015).

When: 6:30pm–8:00pm

Where: Perth Town Hall, Corner Barrack and Hay Streets, Perth VIEW MAP

BOOK HERE

@@@

Friday 11 November 2016

MELBOURNE

MEET SCIENCE’S SOCIAL MEDIA STARS

Science in Public

Join us for a panel discussion with three outstanding scientists who have successfully used social media to build their profiles in science, and the profile of science in the community.  They will share their tips on how they made it work for them, what to post on what channels, which audiences you can reach, and how to deal with the trolls.

  • Will a social media profile help you build your research career?
  • What’s the difference between Twitter, Facebook, Instagram and LinkedIn anyway?
  • How do you use them to promote your work?
  • Are you a #seriousacademic if you tweet?
  • And what even is Snapchat?

Featuring researchers with a passion and talent for science communication:

socialalchemy-1024x682Dr Katie Mack, Astrophysicist, University of Melbourne – Twitter @astrokatie

Dr Euan Ritchie, Ecologist, Deakin University – Twitter @EuanRitchie1

Dr Alan Duffy, Astrophysicist, Swinburne University – Twitter @astroduff

When: 5:30 PM – 8:00 PM

Where: Royal Society of Victoria, 8 La Trobe St, Melbourne VIEW MAP

BOOK HERE

@@@

Monday 14 November 2016

MELBOURNE

Accelerating Innovation at Universities and Partnering with Industry

Carlton Connect

Presented by the Carlton Connect Initiative, Melbourne Networked Society Institute and Melbourne School of Engineering, this workshop is for research scientists, faculty, students, and industry players interested to increase collaboration and value at the intersection of university and industry projects. Departing from the well-known “Bell-Labs Model”, there has been an evolution of how research is done that now includes aspects of use-inspired research, design, and even entrepreneurship. This workshop will cover key issues the emerging models of industry engagement.

More information here: Accelerating Innovation Flyer

Speaker:

speakerProfessor Ikhlaq Sidhu, Chief Scientist and Founding Director of University of California Berkeley’s Center for Entrepreneurship and Technology

Ikhlaq Sidhu is the Chief Scientist and Founding Director of UC Berkeley’s Center for Entrepreneurship & Technology. He received the IEOR Emerging Area Professor Award from his department at Berkeley. Prof Sidhu also founded the Fung Institute for Engineering Leadership. He has been granted over 60 US Patents in networking technology, IP telephony, and mobile computing. He was awarded 3Com Corporation’s Inventor of the Year in 1999. Dr Sidhu also serves as a Senior Fellow of the Applied Innovation Institute and as a Venture Advisor at Onset Ventures, a leading Silicon Valley investment firm.

When: 10:00 AM – 3:00 PM

Where: Woodward Conference Centre, 185 Pelham Street, Carlton, VIC 3053 VIEW MAP

BOOK HERE

@@@

Friday 18-20 November

MACKAY

Startup Weekend Mackay

Startup Weekend Mackay is a 54-hour event designed to provide superior experiential education for technical and non-technical entrepreneurs. Beginning with Friday night pitches, brainstorming, business plan development, and basic prototype creation, Startup Weekend Mackay will culminate in Sunday night demos and presentations. Participants create working start-ups during the event and are able to collaborate with like-minded individuals outside of their daily networks. All teams hear talks by industry leaders and receive valuable feedback from local entrepreneurs. The weekend is centered around action, innovation, and education.

start-up-mackay

When: Event starts at 5:30pm

Where: Central Qld University Mackay, Ooralea Campus, 151 Boundary Road, Ooralea, Mackay, Queensland VIEW MAP

BOOK HERE